Light Mode
$17.41 ↓ -1.94 (-10.01%) Trading Down from the previous close of $19.34, $3.15 below the day’s high of $20.55
+10.45 (+117.55%) / 6M
Momentum, market sentiment, and recent alerts
NVCT reads poor: price sits above one of the two key moving averages, the 12-month move is +228.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.